The Impact of the Pathologic Differentiation (Well or Poorly) and the Degree of Ki-67 Index in Patients with Metastatic WHO Grade 3 GEP-NETs
#1580
Introduction: There is few data for the treatment-outcome with etoposide plus platinum between well differentiated and poorly differentiated metastatic grade 3 GEP-NEC.
Aim(s): Herein, we investigated the impact of pathologic differentiation (well or poorly differentiation) in metastatic grade 3 GEP-NEC patients receiving etoposide and platinum based therapy.
Materials and methods: Herein, we investigated the impact of pathologic differentiation (well or poorly differentiation) in metastatic grade 3 GEP-NEC patients receiving etoposide and platinum based therapy.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Keywords: Ki67 index,
To read the full abstract, please log into your ENETS Member account.